BioSpace News Archive

Report entitled “Over The Hill” outlines how Hill-Rom Holdings, Inc. faces 25-55% downside risk to approximately $45 to $75 per share.

Global Cancer Technology (“GCT”) announced today that it has launched an equity crowdfunding campaign under Regulation CF guidelines.

Indigo Agriculture, a company dedicated to harnessing nature to help farmers sustainably feed the planet, announces the launch of Indigo Acres, a comprehensive new offer for U.S. growers transitioning to regenerative farming practices.

On-site industrial wastewater treatment provider Axine Water Technologies today announced the completion of a long-term test program to validate its electrochemical oxidation technology for treating active pharmaceutical ingredients (APIs) in wastewater.

There is much activity in the nanotechnology & nanomedicine markets as new treatments and human clinical trials are growing at a record pace.

There is currently no cure for amyotrophic lateral sclerosis (ALS). But new research could open up avenues for better diagnosis and more effective treatment.

Blink Health, the digital health company on a mission to make prescription drugs affordable for everyone, has appointed Kathy Reardon as Chief Healthcare Counsel. Reardon joins the company with two decades of experience navigating the legal intricacies of the complex and opaque pharmaceutical supply chain.

A joint study conducted by Precision Pulmonary Diagnostics, Harvard Medical School, Virginia Tech Transportation Institute and the University of Minnesota-Morris has demonstrated that employer-sponsored sleep apnea screening, diagnosis, and treatment yields significant health cost savings in employee health insurance claim costs.

Health Care Service Corporation (HCSC) announced today a multi-state education and outreach campaign aimed at decreasing the number of uninsured and underinsured Americans.

A new research study recently published as an “In Press” article in the Journal of Antivirals & Antiretrovirals [Volume 11, Issue 3, 2019] concludes that “phytomedical compounds, such as the cardenolide oleandrin, may one day represent a cost-effective therapeutic strategy to help combat enveloped virus infections in developing countries with limited access to modern antivirals.”